Inovio Pharmaceuticals, Inc.
INO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001055726
No open-market purchases or sales by Inovio Pharmaceuticals, Inc. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $36.1M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Inovio Pharmaceuticals, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 183 | 3 | 186 | +6 |
| Shares | 116.0M | 18.9K | 127.3M | +11.3M (+9.8%) |
| Value | $200.0M | $33.0K | $198.5M | −$1.46M (−0.7%) |
3 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (30)
Institutions that held Inovio Pharmaceuticals, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
Sold out (24)
Institutions that held Inovio Pharmaceuticals, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Quantbot Technologies LP | 134,457 | $231.0K |
| Qube Research & Technologies Ltd | 96,137 | $166.0K |
| Graham Capital Management, L.P. | 57,338 | $98.0K |
| ExodusPoint Capital Management, LP | 53,544 | $92.0K |
| Y-Intercept (Hong Kong) Ltd | 40,459 | $69.8K |
| Connor, Clark & Lunn Investment Management Ltd. | 28,143 | $49.0K |
| Point72 Hong Kong Ltd | 24,515 | $42.0K |
| Wolverine Trading, LLC | 17,685 | $30.0K |
| Janney Montgomery Scott LLC | 15,740 | $27.0K |
| Jump Financial, LLC | 15,163 | $26.0K |
| Walleye Trading LLC | 11,390 | $20.0K |
| Raymond James Financial Services Advisors, Inc. | 10,070 | $17.0K |
| Macquarie Group Ltd | 5,294 | $14.0K |
| Ellis Investment Partners, LLC | 4,000 | $6.00K |
| City State Bank | 2,000 | $3.00K |
| Group One Trading, L.P. | 1,192 | $2.00K |
| Country Trust Bank | 1,210 | $2.00K |
| Kessler Investment Group, LLC | 542 | $1.00K |
| Brown Brothers Harriman & Co | 33 | $0 |
| McMillion Capital Management Inc | 145 | $0 |
| Hudock, Inc. | 9 | $0 |
| Riggs Asset Managment Co. Inc. | 125 | $0 |
| GPS Wealth Strategies Group, LLC | 50 | $0 |
| Financial Advocates Investment Management | 14,161 | – |
Not filed for Q4 2022 yet (3)
Institutions that held Inovio Pharmaceuticals, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Keebeck Alpha, LP | 16,756 | $29.0K |
| Covington Capital Management | 1,000 | $2.00K |
| Wipfli Financial Advisors LLC, | 1,100 | $2.00K |